Ray Weisbein v. Allergan, Inc., et al
RAY WEISBEIN, individually and on behalf of all others similarly situated |
ALLERGAN, INC., a Delaware corporation, TARA CAPALBO and ANDREW BARTON |
23-55003 |
January 4, 2023 |
U.S. Court of Appeals, Ninth Circuit |
Other Statutory Actions |
Docket Report
This docket was last retrieved on March 8, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 8 Filed order (Deputy Clerk: RGA): The conference previously scheduled for March 21, 2023, is canceled. Appellants motion to dismiss this appeal (Docket Entry No. [ # 7 ]) is granted. Fed. R. App. P. 42(b). The parties shall bear their own costs and attorneys fees on appeal. A copy of this order shall serve as and for the mandate of this court. [12669951] (AF) [Entered: 03/08/2023 03:08 PM] |
Filing 7 Filed (ECF) Appellant Ray Weisbein Unopposed Motion to dismiss case voluntarily pursuant to FRAP 42(b). Date of service: 03/07/2023. [12669127] [23-55003] (Milian, David) [Entered: 03/07/2023 01:37 PM] |
Filing 6 MEDIATION CONFERENCE RESCHEDULED - DIAL-IN AssessmentConference, 03/21/2023, 10:00 a.m. Pacific Time. (originally scheduled on 03/07/2023 ). [12665014] (VS) [Entered: 03/01/2023 01:21 PM] |
Filing 5 MEDIATION CONFERENCE SCHEDULED - DIAL-IN AssessmentConference, 03/07/2023, 11:00 a.m., PACIFIC Time. The briefing schedule previously set by the court remains in effect. See order for instructions and details. [12647147] (VS) [Entered: 02/06/2023 02:35 PM] |
Filing 4 MEDIATION ORDER FILED: By 01/26/2023, counsel to email Circuit Mediator regarding settlement potential. Include Ninth Circuit case name and number in subject line. This communication will be kept confidential, if requested, and should not be filed with the court. The existing briefing schedule remains in effect. SEE ORDER FOR DETAILS. [12629174] (VS) [Entered: 01/12/2023 10:49 AM] |
Filing 3 The Mediation Questionnaire for this case was filed on 01/11/2023. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[12628829]. [23-55003] (AD) [Entered: 01/11/2023 06:58 PM] |
Filing 2 Filed (ECF) Appellant Ray Weisbein Mediation Questionnaire. Date of service: 01/11/2023. [12628338] [23-55003] (Milian, David) [Entered: 01/11/2023 01:37 PM] |
Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Ray Weisbein Mediation Questionnaire due on 01/11/2023. Appellant Ray Weisbein opening brief due 03/06/2023. Appellees Allergan, Inc., Andrew Barton and Tara Capalbo answering brief due 04/05/2023. Appellant's optional reply brief is due 21 days after service of the answering brief. [12623063] (JBS) [Entered: 01/04/2023 03:09 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.